Patient-Reported Outcome Measure Developed for Radionuclide Therapy in Prostate Cancer

The FACT-RNT PRO tool has been developed for measuring symptoms/toxicities among prostate cancer patients receiving RNT.

Related Keywords

Florida , United States , Tampa , Lisa Gudenkauf , Journal Of Nuclear Medicine , Moffitt Cancer Center , Healthday News , Functional Assessment , Cancer Therapy Radionuclide , Chronic Illness Therapy ,